333 related articles for article (PubMed ID: 16036178)
21. Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention.
Surriabre P; Torrico A; Vargas T; Ugarte F; Rodriguez P; Fontaine V
BMC Infect Dis; 2019 Oct; 19(1):842. PubMed ID: 31615443
[TBL] [Abstract][Full Text] [Related]
22. HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor.
Zuna RE; Moore W; Dunn ST
Mod Pathol; 2001 Mar; 14(3):147-51. PubMed ID: 11266518
[TBL] [Abstract][Full Text] [Related]
23. Efficiency of the hybrid capture 2 HPV DNA test in cervical cancer screening. A study by the French Society of Clinical Cytology.
de Cremoux P; Coste J; Sastre-Garau X; Thioux M; Bouillac C; Labbé S; Cartier I; Ziol M; Dosda A; Le Galès C; Molinié V; Vacher-Lavenu MC; Cochand-Priollet B; Vielh P; Magdelénat H;
Am J Clin Pathol; 2003 Oct; 120(4):492-9. PubMed ID: 14560561
[TBL] [Abstract][Full Text] [Related]
24. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
[TBL] [Abstract][Full Text] [Related]
25. Audit of laboratory sensitivity of human papillomavirus and cytology testing in a cervical screening program.
Hortlund M; Mühr LSA; Lagheden C; Hjerpe A; Dillner J
Int J Cancer; 2021 Dec; 149(12):2083-2090. PubMed ID: 34418082
[TBL] [Abstract][Full Text] [Related]
26. An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme.
Sherlaw-Johnson C; Philips Z
Br J Cancer; 2004 Jul; 91(1):84-91. PubMed ID: 15162150
[TBL] [Abstract][Full Text] [Related]
27. Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
Akbari A; Vanden Broeck D; Benoy I; Padalko E; Bogers J; Arbyn M
Virol J; 2018 Oct; 15(1):166. PubMed ID: 30373616
[TBL] [Abstract][Full Text] [Related]
28. Effect of glacial acetic acid pre-treatment of cervical liquid-based cytology specimens on the molecular detection of human papillomavirus.
Moore C; Cuschieri K; McQueen F; Duvall E; Graham C; Cubie HA
Cytopathology; 2013 Oct; 24(5):314-20. PubMed ID: 23379748
[TBL] [Abstract][Full Text] [Related]
29. High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technology.
Geraets DT; Heideman DA; de Koning MN; Snijders PJ; van Alewijk DC; Meijer CJ; van Doorn LJ; Quint WG
J Clin Virol; 2009 Nov; 46 Suppl 3():S21-6. PubMed ID: 20129070
[TBL] [Abstract][Full Text] [Related]
30. Quality assurance in screening strategies.
Miller AB
Virus Res; 2002 Nov; 89(2):295-9. PubMed ID: 12445669
[TBL] [Abstract][Full Text] [Related]
31. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions.
Cuzick J; Sasieni P; Davies P; Adams J; Normand C; Frater A; van Ballegooijen M; van den Akker-van Marle E
Br J Cancer; 2000 Sep; 83(5):561-5. PubMed ID: 10944591
[TBL] [Abstract][Full Text] [Related]
32. Human Papillomavirus negative but dyskaryotic cervical cytology: re-analysis of molecular testing.
Peevor R; Bowden S; Jones J; Fiander AN; Hibbitts S
J Clin Virol; 2009 Apr; 44(4):322-4. PubMed ID: 19264544
[TBL] [Abstract][Full Text] [Related]
33. HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system.
Frayle H; Gori S; Rizzi M; Graziani BN; Vian E; Giorgi Rossi P; Del Mistro A
BMC Womens Health; 2019 Mar; 19(1):47. PubMed ID: 30909894
[TBL] [Abstract][Full Text] [Related]
34. Ensuring quality in cervical screening programmes based on molecular human papillomavirus testing.
Cuschieri K; Schuurman R; Coughlan S
Cytopathology; 2019 May; 30(3):273-280. PubMed ID: 30657615
[TBL] [Abstract][Full Text] [Related]
35. Psychological Impact of Primary Screening (PIPS) for HPV: a protocol for a cross-sectional evaluation within the NHS cervical screening programme.
McBride E; Marlow L; Forster AS; Moss S; Myles J; Kitchener H; Patnick J; Waller J
BMJ Open; 2016 Dec; 6(12):e014356. PubMed ID: 28011816
[TBL] [Abstract][Full Text] [Related]
36. Interlaboratory reproducibility and proficiency testing within the human papillomavirus cervical cancer screening program in Catalonia, Spain.
Ibáñez R; Félez-Sánchez M; Godínez JM; Guardià C; Caballero E; Juve R; Combalia N; Bellosillo B; Cuevas D; Moreno-Crespi J; Pons L; Autonell J; Gutierrez C; Ordi J; de Sanjosé S; Bravo IG
J Clin Microbiol; 2014 May; 52(5):1511-8. PubMed ID: 24574284
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance.
Prétet JL; Arroyo Mühr LS; Cuschieri K; Fellner MD; Correa RM; Picconi MA; Garland SM; Murray GL; Molano M; Peeters M; Van Gucht S; Lambrecht C; Broeck DV; Padalko E; Arbyn M; Lepiller Q; Brunier A; Silling S; Søreng K; Christiansen IK; Poljak M; Lagheden C; Yilmaz E; Eklund C; Thapa HR; Querec TD; Unger ER; Dillner J
J Clin Virol; 2024 Apr; 171():105657. PubMed ID: 38401369
[TBL] [Abstract][Full Text] [Related]
38. Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review.
Madzima TR; Vahabi M; Lofters A
Can Fam Physician; 2017 Aug; 63(8):597-601. PubMed ID: 28807952
[TBL] [Abstract][Full Text] [Related]
39. [Implementation of DNA-HPV primary screening in Italian cervical cancer screening programmes. Results of the MIDDIR Project].
Di Stefano F; Giorgi Rossi P; Carozzi F; Ronco G; Cacciani L; Vecchi S; Naldoni C; Segnan N;
Epidemiol Prev; 2017; 41(2):116-124. PubMed ID: 28627153
[TBL] [Abstract][Full Text] [Related]
40. Hybrid capture II and polymerase chain reaction for identifying HPV infections in samples collected in a new collection medium: a comparison.
Nonogaki S; Wakamatsu A; Longatto Filho A; Pereira SM; Utagawa ML; Ferreira Alves VA; Di Loreto C; Sakamoto Maeda MY; Lima TP; Roteli-Martins C; Syrjänen K
Acta Cytol; 2004; 48(4):514-20. PubMed ID: 15296342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
